Top

Diagnostic Pathology

Published in:

Open Access 01-12-2016 | Case Report

Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case

Authors: Chelsey D. Deel, Richard A. Allen, Laura L. Holman, Rosemary E. Zuna

Published in: Diagnostic Pathology | Issue 1/2016

Abstract

Background

Fallopian tube involvement by cervical carcinoma has rarely been documented, with literature reports focusing primarily on squamous cell carcinoma.

Case presentation

In this report, we present the case of a 50 year old woman who presented with an abnormal Pap test with atypical squamous and glandular cells. A loop electrosurgical excision procedure (LEEP) was performed and led to the diagnosis of stage IB1 endocervical adenocarcinoma. Subsequent radical hysterectomy, bilateral salpingo-oophorectomy, and bilateral pelvic lymph node dissection showed a well-differentiated endocervical adenocarcinoma of usual type with superficial spread to the endometrium and right fallopian tube. The patient received no adjuvant therapy and has remained without evidence of disease.

Conclusions

While the advent of more extensive fallopian tube sampling has led to increased discovery and discussion of fallopian tube involvement by metastatic carcinoma, its impact on treatment and prognosis remains to be seen.

Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19:58–64.CrossRefPubMed

Shanesmith R, Allen RA, Moore WE, Kingma DW, Caughron SK, Gillies EM, Dunn ST. Comparison of two line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cells carcinomas. Diagn Microbiol Infect Dis. 2011;70:240–5.CrossRefPubMed

SEER Stat Fact Sheets. Cervix Uteri Cancer. SEER: Surveillance, Epidemiology, and End Results Program [database online]. Bethesda: National Cancer Institute; 1996.

Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer. 2004;100(5):1035–44.CrossRefPubMed

Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol. 2000;78:97–105.CrossRefPubMed

Gungor T, Altinkaya SO, Ozat M, et al. Unusual form of superficial spreading squamous cell carcinoma of cervix involving the endometrium, bilateral tubes and ovaries: a case report with literature review. Arch Gynecol Obstet. 2011;283:323–7.CrossRefPubMed

Jaiman S, Surampudi K, Gundabattula SR, Garg D. Bilateral ovarian metastatic squamous cell carcinoma arising from the uterine cervix and eluding the Mullerian mucosa. Diagn Pathol. 2014;9:109.CrossRefPubMedPubMedCentral

Nakanishi T, Wakai K, Ishikawa H, et al. A Comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol. 2001;82:504–9.CrossRefPubMed

Reyes C, Murali R, Park KJ. Secondary involvement of the adnexa and uterine corpus by carcinomas of the uterine cervix. A detailed morphologic description. Int J Gynecol Pathol. 2015;34(6):551–63.CrossRefPubMed

10.

Rabban JT, Vohra P, Zaloudek CJ. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia. Am J Surg Pathol. 2015;39(1):35–51.CrossRefPubMed

11.

Ronnett BM, Yemelyanova AV, Vang R, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008;32(12):1835–53.CrossRefPubMed

12.

Hashi A, Yuminamochi T, Murata S, et al. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium and peritoneum. Int J Gynecologic Pathol. 2003;22(4):374–7.CrossRef

13.

Crum CP. Intercepting pelvic cancer in the distal fallopian tube: Theories and realities. Mol Oncol. 2009;3(2):165–70.CrossRefPubMedPubMedCentral

14.

Singh N, Gilks CB, Wilkinson N, McCluggage WG. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum. Histopathology. 2015;67(3):331–7.CrossRefPubMed

15.

Protocol for the Examination of Specimens from Patients with Carcinoma of the Uterine Cervix. College of American Pathologists Cancer Protocol Templates. December 2013. Available at: http://www.cap.org/CANCERPROTOCOLS. Accessed 23 June 2015.

Title: Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case
Authors: Chelsey D. Deel
Richard A. Allen
Laura L. Holman
Rosemary E. Zuna
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Diagnostic Pathology / Issue 1/2016
Electronic ISSN: 1746-1596
DOI: https://doi.org/10.1186/s13000-016-0529-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case

Abstract

Background

Case presentation

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Maxillary calcifying epithelial odontogenic tumor with sinus and buccal vestibule extension: a case report and immunohistochemical study

Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen’s disease

Retraction note: Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy

CDC73 gene mutations in sporadic ossifying fibroma of the jaws

Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study

Retraction note: Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients